Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON49821
NL-OMON49821
Not yet recruiting
Not Applicable

Validation and implementation of rapid testing for SARS-CoV-2 in the primary care setting - COVID-19 rapid test in urgent primary care

HADOKS0 sites1,500 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
HADOKS
Enrollment
1500
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
HADOKS

Eligibility Criteria

Inclusion Criteria

  • •All patients 18 years and older who visit the corona urgent primary care
  • •facility of the HADOKS (location Haga, Leyweg, The Hague) or the SHR/DDDB
  • •(location Alrijne, Leiderdorp).

Exclusion Criteria

  • •Children younger than 18 years of age.
  • •Insufficient understanding of the Dutch language.
  • •Recent (\< 12 hours) intake of alcohol.
  • •Administration of remdesivir and/or dexamethasone before study procedures.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Evaluantion of a new rapid diagnostic test to indetify patients with resistance for tuberculosis´ drugs in BrazilTuberculosisTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantSpecial screening examination for respiratory tuberculosisA00-B99
RBR-3jpsv2Programa Nacional de Controle da Tuberculose CGPNCT / DEVIT Secretaria de Vigilância em Saúde/Ministério da Saúde
Not yet recruiting
Not Applicable
Evaluation study of a rapid test and treatments for Chagas disease in Bahia, BrazilMass ScreeningDrug therapyC01.920.625
RBR-5zfkxdyCentro de Pesquisas Gonçalo Moniz
Not yet recruiting
Phase 2
Development of standard procedure of Uttara Basti including its validation and reliability testing.Health Condition 1: N971- Female infertility of tubal origin
CTRI/2023/05/053137ATIONAL INSTITUTE OF AYURVEDA
Not yet recruiting
Not Applicable
A performance evaluation study for the testing of DNA extracted from either tumor tissue biopsy samples or plasma, using the therascreen® EGFR Plus RGQ PCR Kit, from subjects with Non-Small Cell Lung Cancer, being screened for inclusion in Taiho Oncology, Inc*s Clinical Trial (Protocol No. 10073010).Lung CancerNon Small Cell Lung Cancer10038666
NL-OMON56744QIAGE15
Completed
Not Applicable
Reliability and Validity of a new test method to measure the ability for physical relaxatioWe examine both healthy people and people with underlying health conditions.
DRKS00030777ni-Zentrum Naturheilkunde Freiburg94